Pharmabiz

Cynata Therapeutics completes patient enrolment in phase 2 trial of CYP-001 in adults with newly diagnosed, high risk aGvHD

Cynata Therapeutics completes patient enrolment in phase 2 trial of CYP-001 in adults with newly diagnosed, high risk aGvHD: Melbourne, Australia Tuesday, December 16, 2025, 14:00 ...
Pharmabiz

DPGU faculty wins Rs. 1.1 crore ICMR grant for developing advanced biomaterial for diabetic wound healing

DPGU faculty wins Rs. 1.1 crore ICMR grant for developing advanced biomaterial for diabetic wound healing: Our Bureau, Bengaluru Tuesday, December 16, 2025, 13:50 Hrs [IST] Dnyaan ...
Pharmabiz

Hanahealth by DSS Imagetech takes GERI time-lapse incubator pan India

Hanahealth by DSS Imagetech takes GERI time-lapse incubator pan India: Our Bureau, Mumbai Tuesday, December 16, 2025, 13:40 Hrs [IST] Reiterating its commitment to revolutionising ...
Pharmabiz

IMA Kurukshetra hosts special session on drugs and cosmetics act

IMA Kurukshetra hosts special session on drugs and cosmetics act: Our Bureau, Chennai Tuesday, December 16, 2025, 13:30 Hrs [IST] The Indian Medical Association (IMA) Kurukshetra ...
Pharmabiz

GENESIS Pharma to distribute and commercialize Otsuka Pharmaceutical’s donidalorsen for hereditary angioedema in Central and Eastern Europe

GENESIS Pharma to distribute and commercialize Otsuka Pharmaceutical’s donidalorsen for hereditary angioedema in Central and Eastern Europe: Athens, Greece Tuesday, December 16, ...
Pharmabiz

Bioretec’s RemeOs DrillPin receives US FDA Breakthrough Device Designation

Bioretec’s RemeOs DrillPin receives US FDA Breakthrough Device Designation: Finland Tuesday, December 16, 2025, 13:00 Hrs [IST] Bioretec Oy (Bioretec), a pioneer in biodegradabl ...
Pharmabiz

Sanofi’s PERSEUS phase 3 study of tolebrutinib in primary progressive multiple sclerosis fails to meet primary endpoint

Sanofi’s PERSEUS phase 3 study of tolebrutinib in primary progressive multiple sclerosis fails to meet primary endpoint: Paris Tuesday, December 16, 2025, 11:00 Hrs [IST] Sanofi ...
Pharmabiz

Haryana DC targets 100% Schedule M compliance in MSME sector through risk-based audits and continuous training

Haryana DC targets 100% Schedule M compliance in MSME sector through risk-based audits and continuous training: Tuesday, December 16, 2025, 08:00 Hrs [IST] Lalit Kumar Goel, State ...
Pharmabiz

3rd Edition of Remarkable Women Camaraderie 2026 & Awards

The 3rd Edition of Remarkable Women Camaraderie 2026 & Awards, set to take place on February 6, 2026, in Goa, is born from the belief that when women come together, exchange stories, and uplift one ...
Pharmabiz

World Health Organization launches call for high-level experts to join the Science Council

World Health Organization launches call for high-level experts to join the Science Council: Geneva Tuesday, December 16, 2025, 09:00 Hrs [IST] The World Health Organization (WHO) ...
Pharmabiz

India’s lifescience starts-ups see regulatory compliance as a key hurdle for growth

India’s lifescience starts-ups see regulatory compliance as a key hurdle for growth: Nandita Vijayasimha, Bengaluru Tuesday, December 16, 2025, 08:00 Hrs [IST] Indian lifescienc ...
Pharmabiz

IPC 2025 to ignite innovation, knowledge & industry synergy paving promising avenues for pharma business

IPC 2025 to ignite innovation, knowledge & industry synergy paving promising avenues for pharma business: Nandita Vijaysimha, Bengaluru Tuesday, December 16, 2025, 08:00 Hrs [IST] ...